These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 2465457)

  • 21. Comparison of the effects of a cell saver and low-dose aprotinin on blood loss and homologous blood usage in patients undergoing valve surgery.
    Tempe DK; Banerjee A; Virmani S; Mehta N; Panwar S; Tomar AS; Ghambeer DK; Nigam M
    J Cardiothorac Vasc Anesth; 2001 Jun; 15(3):326-30. PubMed ID: 11426363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High dose aprotinin to reduce blood loss in patients undergoing redo open heart surgery.
    Biagini A; Comite C; Russo V; Salerno ML; Gemignani R; Pardelli S; Baccellini M; Baroni M; Pugliese S; Maffei S
    Acta Anaesthesiol Belg; 1992; 43(3):181-6. PubMed ID: 1280394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose aprotinin modulates the balance between proinflammatory and anti-inflammatory responses during coronary artery bypass graft surgery.
    Tassani P; Augustin N; Barankay A; Braun SL; Zaccaria F; Richter JA
    J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):682-6. PubMed ID: 11139109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of different forms of aprotinin during cardiopulmonary bypass.
    De Bakker A; De Hert S; Vlaeminck R; Delrue G; Govaerts E; Vermeyen K
    Acta Anaesthesiol Belg; 1993; 44(2):45-51. PubMed ID: 7694437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defining the role of aprotinin in heart transplantation.
    Prendergast TW; Furukawa S; Beyer AJ; Eisen HJ; McClurken JB; Jeevanandam V
    Ann Thorac Surg; 1996 Sep; 62(3):670-4. PubMed ID: 8783991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of two aprotinin dosage regimens in pediatric patients having cardiac operations. Influence on platelet function and blood loss.
    Boldt J; Knothe C; Zickmann B; Wege N; Dapper F; Hempelmann G
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):705-11. PubMed ID: 7682266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy.
    Lu H; Du Buit C; Soria J; Touchot B; Chollet B; Commin PL; Conseiller C; Echter E; Soria C
    Thromb Haemost; 1994 Sep; 72(3):438-43. PubMed ID: 7531877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
    Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
    Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery.
    Kikura M; Levy JH; Tanaka KA; Ramsay JG
    J Am Coll Surg; 2006 Feb; 202(2):216-22; quiz A44-5. PubMed ID: 16427545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery.
    Jamieson WR; Dryden PJ; O'Connor JP; Sadeghi H; Ansley DM; Merrick PM
    Circulation; 1997 Nov; 96(9 Suppl):II-96-100; discussion II-100-1. PubMed ID: 9386082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemostasis in patients undergoing extracorporeal circulation: the effect of aprotinin (Trasylol).
    Lu H; Soria C; Commin PL; Soria J; Piwnica A; Schumann F; Regnier O; Legrand Y; Caen JP
    Thromb Haemost; 1991 Dec; 66(6):633-7. PubMed ID: 1724577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Can administration of trasylol in reduced Hammersmith dosage with simultaneous transfusion of autologous blood meet the requirements of open heart surgery?].
    Gschossmann J; Prackl P; Siedlecki J; Binder W; Behr W; Eckart J; Struck E
    Helv Chir Acta; 1993 Dec; 60(3):427-33. PubMed ID: 7509784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of low doses of aprotinin in heart surgery].
    Blanco E; Blanco J; Bóveda S; Sierra J; Rubio J; Durán D; Alvarez J
    Rev Esp Anestesiol Reanim; 1994; 41(3):168-71. PubMed ID: 7520188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose and high-dose aprotinin improve hemostasis in coronary operations.
    Speekenbrink RG; Wildevuur CR; Sturk A; Eijsman L
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):523-30. PubMed ID: 8751522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plateletpheresis before redo CABG diminishes excessive blood transfusion.
    Christenson JT; Reuse J; Badel P; Simonet F; Schmuziger M
    Ann Thorac Surg; 1996 Nov; 62(5):1373-8; discussion 1378-9. PubMed ID: 8893571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting.
    Lindvall G; Sartipy U; van der Linden J
    Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages.
    Golański R; Golański J; Chizyński K; Iwaszkiewicz A; Zasłonka J; Pietrucha T; Chrul S; Watała C
    Med Sci Monit; 2000; 6(4):722-8. PubMed ID: 11208399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operation.
    Havel M; Teufelsbauer H; Knöbl P; Dalmatiner R; Jaksch P; Zwölfer W; Müller M; Vukovich T
    J Thorac Cardiovasc Surg; 1991 Jun; 101(6):968-72. PubMed ID: 1710009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of blood transfusion requirement in open heart surgery by administration of high doses of aprotinin--preliminary results.
    Fraedrich G; Weber C; Bernard C; Hettwer A; Schlosser V
    Thorac Cardiovasc Surg; 1989 Apr; 37(2):89-91. PubMed ID: 2471287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood loss and use of blood in internal mammary artery and saphenous vein bypass grafting with and without adding a single, low-dose of aprotinin (2 million units) to the pump prime.
    Schönberger JP; van Zundert A; Bredée JJ; Gardien M; Everts PA; Bavinck JH; Berreklouw E; Wildevuur CR
    Acta Anaesthesiol Belg; 1992; 43(3):187-96. PubMed ID: 1280395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.